Resolute Financial, LLC E Ffector Therapeutics, Inc. Transaction History

Resolute Financial, LLC

  • $118 Million
  • Q4 2022

A detailed history of Resolute Financial, LLC transactions in E Ffector Therapeutics, Inc. stock. As of the latest transaction made, Resolute Financial, LLC holds 31,000 shares of EFTR stock, worth $0. This represents 0.01% of its overall portfolio holdings.

Number of Shares
31,000
Previous 31,000 -0.0%
Holding current value
$0
Previous $18,000 27.78%
% of portfolio
0.01%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.08 - $1.41 $80 - $1,410
1,000 Added 3.33%
31,000 $18,000
Q2 2022

Aug 02, 2022
BUY
$1.3 - $3.84 $39,000 - $115,200
30,000 New
30,000 $43,000

Others Institutions Holding EFTR

# of Institutions
5
Shares Held
6.46M
Call Options Held
0
Put Options Held
0
View Full List

About eFFECTOR Therapeutics, Inc.

EFTR Quotes by TradingView
  • Ticker EFTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,452,800
  • Description
  • eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-sma...
More about EFTR
Track This Portfolio

Track Resolute Financial, LLC Portfolio

Follow Resolute Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Resolute Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Resolute Financial, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email